Boswellia Extract 250 mg 90 caps
Food supplement declared in France, declaration No 2019-4-808
Boswellia Extract 250 mg 90 caps (PROZIS) is a food supplement declared in France. Status: withdrawn from the market on 16 December 2023. Main ingredients: Boswellia serrata 750 mg per day. 1 point in its composition requires a check (prohibited substance, dose or novel food).
- Brand
- PROZIS
- Food business operator placing the product on the market
- Prozis.Com, S.A.
- Status
- Withdrawn from the market on 16 December 2023
- Form
- Capsule
- Daily dose
- 3 gélules
- Directions for use
- Prendre 1 gélule 3 fois par jour.
- Intended populations
- Men, Women
Declaration 163694, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Boswellia serrata Roxb. ex Colebr. | Résine | Extrait sec hydroalcoolique | 750 mg |
Additives
E171
Other ingredients
maltodextrine, gélatine
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la portion journalière recommandée. Ce produit ne doit pas remplacer une alimentation variée et équilibrée et un mode de vie sain. Maintenir hors de la portée des enfants. Conserver bien fermé dans l'emballage d'origine dans un endroit frais et sec, à l'abri de la lumière directe du soleil.
Regulatory points
- À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.
- Information
Withdrawn from the market on 16 December 2023, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Boswellia Extract 250mg 90 caps PROZIS, declared in 2021, withdrawn from the market : different composition: 0 ingredient(s) added, 1 missing
Brand : PROZIS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Boswellia Extract 250 mg 90 caps (PROZIS): composition and regulation”, https://compoatlas.com/en/supplements/products/163694-boswellia-extract-250-mg-90-caps, updated 15 November 2026.